Small Molecule Antibacterial
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
74
NCT02518607
Safety, Blood Levels and Effects of MGB-BP-3
Phase: Phase 1
Role: Lead Sponsor
Start: Jul 31, 2015
Completion: Nov 30, 2015
NCT03824795
Study to Assess Safety, Tolerability and Efficacy of Incremental Doses of MGB-BP-3 in Patients With CDAD
Phase: Phase 2
Start: Feb 7, 2019
Completion: Apr 3, 2020
Loading map...